In 2012, the UGP achieved 91% of its total target, with oncology achieving 98% of its target and ICU achieving 36% of its target. Oncology made up 95% of total sales and 48% of total expenses, while ICU was 5% of sales and 52% of expenses. Strong points in 2012 included winning several government tenders and preparing challenges for 2013. The sales team grew to 23 members with strengths in various roles to continue the company's success.